Jake101069

Jason

I prefer diversified high risk, high reward investing. Biotechs are a current favorite. In 2014, up 34.5% (117 times the S&P), and Stocktwits is a big reason. Happy with the result, but still cautious.

DC
Joined 12/2012

3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.

Introducing Litepaper, a newsletter by Stocktwits. Your lens into the world of crypto.
Join the conversation.This is where all the magic happens.